Works matching IS 01676997 AND DT 2005 AND VI 23 AND IP 3

Results: 10

Phase II trial of dolastatin-10 in patients with advanced breast cancer.

Published in:

Investigational New Drugs, 2005, v. 23, n. 3, p. 257, doi. 10.1007/s10637-005-6735-y

By:

Edith A. Perez;
David W. Hillman;
Paul A. Fishkin;
James E. Krook;
Winston W. Tan;
Phillip A. Kuriakose;
Steven R. Alberts;
Shaker R. Dakhil

Publication type:

Article

Phase I trial of menadiol diphosphate (vitamin K3) in advanced malignancy.

Published in:

Investigational New Drugs, 2005, v. 23, n. 3, p. 235, doi. 10.1007/s10637-005-6731-2

By:

Dean Lim;
Robert J. Morgan;
Steven Akman;
Kim Margolin;
Brian I. Carr;
Lucille Leong;
Oluwole Odujinrin;
James H. Doroshow

Publication type:

Article

Cryptophycins-309, 249 and other cryptophycin analogs: Preclinical efficacy studies with mouse and human tumors.

Published in:

Investigational New Drugs, 2005, v. 23, n. 3, p. 213, doi. 10.1007/s10637-005-6729-9

By:

Jian Liang;
Richard E. Moore;
Eric D. Moher;
John E. Munroe;
Rima S. Al-awar;
David A. Hay;
David L. Varie;
Tony Y. Zhang;
James A. Aikins;
Michael J. Martinelli;
Chuan Shih;
James E. Ray;
Lowell L. Gibson;
Vasu Vasudevan;
Lisa Polin;
Kathryn White;
Juiwanna Kushner;
Chiab Simpson;
Susan Pugh;
Thomas H. Corbett

Publication type:

Article

Multi-centre Phase II trial of the polyamine synthesis inhibitor SAM486A (CGP48664) in patients with metastatic melanoma.

Published in:

Investigational New Drugs, 2005, v. 23, n. 3, p. 253, doi. 10.1007/s10637-005-6734-z

By:

Michael J. Millward;
Anthony Joshua;
Rick Kefford;
Steinar Aamdal;
Damien Thomson;
Peter Hersey;
Guy Toner;
Kevin Lynch

Publication type:

Article

Induction of apoptosis by flavopiridol unrelated to cell cycle arrest in germ cell tumour derived cell lines.

Published in:

Investigational New Drugs, 2005, v. 23, n. 3, p. 205, doi. 10.1007/s10637-005-6728-x

By:

Frank Mayer;
Sandra Mueller;
Elke Malenke;
M. Kuczyk;
Carsten Bokemeyer

Publication type:

Article

Weekly irinotecan plus UFT and leucovorin as first-line chemotherapy of patients with advanced colorectal cancer.

Published in:

Investigational New Drugs, 2005, v. 23, n. 3, p. 243

By:

M. Mndez;
P. G. Alfonso;
E. Pujol;
E. Gonzlez;
C. Castaon;
P. Cerezuela;
Y. Lpez-Mateos;
J. J. Cruz

Publication type:

Article

A phase I trial of irinotecan (CPT-11) with amifostine in patients with metastatic colorectal cancer.

Published in:

Investigational New Drugs, 2005, v. 23, n. 3, p. 241, doi. 10.1007/s10637-005-6732-1

By:

Heather Wakelee;
George A. Fisher

Publication type:

Article

Semi-physiological model describing the hematological toxicity of the anti-cancer agent indisulam.

Published in:

Investigational New Drugs, 2005, v. 23, n. 3, p. 225, doi. 10.1007/s10637-005-6730-3

By:

Charlotte van Kesteren;
Anthe S. Zandvliet;
Mats O. Karlsson;
Ron A. A. Matht;
Cornelis J. A. Punt;
Jean-Pierre Armand;
Eric Raymond;
Alwin D. R. Huitema;
Christian Dittrich;
Herlinde Dumez;
Henri H. Roch;
Jean-Pierre Droz;
Miroslav Ravic;
S. Murray Yule;
Jantien Wanders;
Jos H. Beijnen;
Pierre Fumoleau;
Jan H. M. Schellens

Publication type:

Article

A mutated p53 status did not prevent the induction of apoptosis by sulforaphane, a promising anti-cancer drug.

Published in:

Investigational New Drugs, 2005, v. 23, n. 3, p. 195, doi. 10.1007/s10637-005-6727-y

By:

Carmela Fimognari;
Luca Sangiorgi;
Silvia Capponcelli;
Michael Nsse;
Silvia Fontanesi;
Fausto Berti;
Silvia Soddu;
Giorgio Cantelli-Forti;
Patrizia Hrelia

Publication type:

Article

Randomized phase II evaluation of aprinocarsen in combination with gemcitabine and cisplatin for patients with advanced/metastatic non-small cell lung cancer.

Published in:

Investigational New Drugs, 2005, v. 23, n. 3, p. 263, doi. 10.1007/s10637-005-6736-x

By:

Johan Vansteenkiste;
Jean-Luc Canon;
Henrik Riska;
Robert Pirker;
Patrick Peterson;
William John;
Pekka Mali;
Michael Lahn

Publication type:

Article